Press Releases 2021 2020 2019 all March 4, 2021 Dyne Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights March 4, 2021 Dyne Therapeutics Appoints Wildon Farwell, M.D., MPH, as Chief Medical Officer February 8, 2021 Dyne Therapeutics Appoints Ashish Dugar, Ph.D., MBA, Senior Vice President, Global Head of Medical Affairs January 20, 2021 Dyne Therapeutics Announces Pricing of $168 Million Public Offering January 10, 2021 Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical Study January 5, 2021 Dyne Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
